Pacific Edge Past Earnings Performance

Past criteria checks 0/6

Pacific Edge's earnings have been declining at an average annual rate of -14.7%, while the Biotechs industry saw earnings growing at 13.2% annually. Revenues have been growing at an average rate of 33.2% per year.

Key information

-14.7%

Earnings growth rate

-7.4%

EPS growth rate

Biotechs Industry Growth9.6%
Revenue growth rate33.2%
Return on equity-70.8%
Net Margin-127.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Pacific Edge makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:PEB Revenue, expenses and earnings (NZD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2423-292814
30 Jun 2424-293213
31 Mar 2425-303512
31 Dec 2325-313711
30 Sep 2326-323910
30 Jun 2323-29379
31 Mar 2321-27358
31 Dec 2219-24327
30 Sep 2216-21286
30 Jun 2215-21256
31 Mar 2213-20225
31 Dec 2112-18205
30 Sep 2112-16185
30 Jun 2110-15175
31 Mar 219-14155
31 Dec 207-15144
30 Sep 206-17144
30 Jun 205-18144
31 Mar 205-19154
31 Dec 195-19155
30 Sep 195-19156
30 Jun 195-18155
31 Mar 195-18154
31 Dec 185-18152
30 Sep 185-18150
30 Jun 185-19150
31 Mar 185-20160
31 Dec 174-20180
30 Sep 173-21200
30 Jun 174-22170
31 Mar 174-23140
31 Dec 166-2190
30 Sep 168-2040
30 Jun 167-1840
31 Mar 166-1630
31 Dec 155-1530
30 Sep 154-1530
30 Jun 154-1430
31 Mar 153-1230
31 Dec 143-1140
30 Sep 142-1050
30 Jun 141-1050
31 Mar 141-1050
31 Dec 130-930

Quality Earnings: PEB is currently unprofitable.

Growing Profit Margin: PEB is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PEB is unprofitable, and losses have increased over the past 5 years at a rate of 14.7% per year.

Accelerating Growth: Unable to compare PEB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PEB is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.1%).


Return on Equity

High ROE: PEB has a negative Return on Equity (-70.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 21:43
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pacific Edge Limited is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anubhav SaxenaBell Potter
null nullBrookline Capital Markets
Gregory MainCredit Suisse